Repligen Corp (RGEN)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$134.00

Buy

$180.00

arrow-down$-4.27 (-2.64%)

Prices updated at 12 Dec 2025, 22:59 EST

Prices minimum 15 mins delay

Prices in USD

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	632m	634m
	278m	275m
	17m	-32m
	2.71	-5.03
	36m	-26m
	145m	80m
Sales, General and administrative	219m	263m
Interest expenses	3m	21m
Provision for income taxes	21m	-2m
Operating expenses	261m	307m
Income before taxes	57m	-27m
Net income available to common shareholders	36m	-26m
	0.75	-0.46
Net interest income	-11m	-23m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.74	-0.46
Free cash flow per share	1.7114	2.3475
Book value/share	35.6589	35.9534
Debt equity ratio	0.324057	0.340212

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	1,111m	1,066m
Current liabilities	158m	127m
Total capital	2,481m	2,498m
Total debt	712m	686m
Total equity	1,971m	1,973m
Total non current liabilities	-	-
Loans	510m	526m
Total assets	2,824m	2,830m
Total liabilities	-	-
Cash and cash equivalents	751m	757m
Common stock	56m	56m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	523m	751m
Cash dividends paid	-	-
	75m	142m
Investments (gains) losses	-123m	-86m
	751m	757m
Net income	-	-
	114m	175m
	-39m	-33m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.